87771-40-2
87771-40-2
Chemical Structure
Ioversol
Synonym(s): MP-328
- CAS No.: 87771-40-2
- Formula:C18H24I3N3O9
- Molecular Weight:807.11
IUPAC Name: N1,N3-bis(2,3-dihydroxypropyl)-5-(2-hydroxy-N-(2-hydroxyethyl)acetamido)-2,4,6-triiodoisophthalamide
InChIKey: AMDBBAQNWSUWGN-UHFFFAOYSA-N
SMILES: O=C(C1=C(I)C(N(C(CO)=O)CCO)=C(I)C(C(NCC(O)CO)=O)=C1I)NCC(O)CO
Biological Activity: Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal[1][2][3][4].
| Cat. No. | 상품명 | Purity | 제품 설명 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Ioversol | 98.0% | Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ioversol (Standard) | ≥98% | Ioversol (Standard) is the analytical standard of Ioversol. This product is intended for research and analytical applications. Ioversol (MP-328) is a nonionic iodinated contrast medium (CM) that is used during a CT scan or x-ray in animal experiment. Ioversol does not damage the blood-brain barrier (BBB) in animal. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ioxilan | 98.04% | Ioxilan is a low-osmolar, nonionic and tri-iodinated diagnostic contrast agent. Ioxilan is also an X-ray contrast agent for excretory urography and contrast enhanced computed tomographic (CECT) imaging of the head and body. Intravascular injection results in opacification of vessels in the path of flow of the contrast medium, permitting radiographic visualization of the internal structures of the human body until significant hemodilution occurs. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iopentol (Standard) | ≥98% | Iopentol (Standard) is the analytical standard of Iopentol. This product is intended for research and analytical applications. Iopentol is a non-ionic, intravascular contrast media. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iomeprol | 99.36% | Iomeprol is a nonionic X-ray contrast agent with low osmotic pressure, stable chemical properties, and can withstand high temperature sterilization. Iomeprol can be widely used in vascular, body cavity, and gastrointestinal angiography examinations. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iodopropamine-d3 | Iodopropamine-d3 is the deuterium labeled Iodopropamine. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iohexol | 99.54% | Iohexol is a non-ionic, water-soluble contrast agent used as a reference marker for the determination of glomerular filtration rate (GFR) at the level of renal function. Iohexol can be used for contrast in myelography, computerized tomography (cisternography, ventriculography) and MicroCT imaging. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iohexol-d5 | 99.97% | Iohexol-d5 is deuterium labeled Iohexol. Iohexol is a radiographic contrast agent and can be applied for myelography, computerized tomography?(cisternography, ventriculography) and MicroCT imaging in vivo. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iopromide (Standard) | ≥98% | Iopromide (Standard) is the analytical standard of Iopromide. This product is intended for research and analytical applications. Iopromide is a non-ionic, monomeric, iodine-based contrast medium for intravascular administration. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iomeprol intermediate-1 | 99.59% | Iomeprol intermediate-1 (compound 5) is an iodinated polysaccharide compound used in the synthesis of contrast agents. The amino group of Iomeprol intermediate-1 can be coupled to the carboxyl group of the D-glucuronide subunit of non-animal stable hyaluronic acid (NASHA), providing a water-soluble, radiopaque moiety. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Iomeprol hydrolysate-1 (Standard) | ≥98% | Iomeprol hydrolysate-1 (Standard) is the analytical standard of Iomeprol hydrolysate-1. This product is intended for research and analytical applications. Iomeprol hydrolysate-2 (compound A) is iomeprol hydrolyzate, a key intermediate in the production of Iodixanol (HY-B1426) and Iohexol (HY-B0594) X-ray contrast agents. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Ioversol hydrolysate-1 | Ioversol hydrolysate-1 is a hydrolyzate of Ioversol (HY-B1410), a non-ionic iodinated contrast agent (CM) used in CT scans or X-rays in animal experiments. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Yang D, et al. Selective inhibition of the reverse mode of Na(+)/Ca(2+) exchanger attenuates contrast-induced cell injury. Am J Nephrol. 2013;37(3):264-73. doi: 10.1159/000348526. Epub 2013 Mar 13. [Content Brief]
- [2]. Heyman SN, et al. Effects of ioversol versus iothalamate on endothelin release and radiocontrast nephropathy. Invest Radiol. 1993 Apr;28(4):313-8. [Content Brief]
- [3]. J Ueda, et al. Elimination of ioversol by hemodialysis. Acta Radiol. 1996 Sep;37(5):826-9. [Content Brief]
- [4]. N Motoji , et al. Comparison of the effects of ioversol and other contrast media on the blood-brain barrier. Biol Pharm Bull. 1994 Feb;17(2):257-61. [Content Brief]
